Skip to main content

Showing 31 - 40 of 6835 results

JAMDA

July 6, 2020

Lack of Effect of a Multicomponent Palliative Care Program for Nursing Home Residents on Hospital Use in the Last Month of Life and on Place of Death: A Secondary Analysis of a Multicountry Cluster Randomized Control Trial

PACE Steps to Success is a 1-year train-the-trainer program aiming to integrate nonspecialist palliative care into nursing homes via staff education and organizational support. In this study, we aimed to explore whether this program resulted in changes in residents' hospital use and place of death. ...
Spotlight

December 12, 2025

Care Continuum 26: Gain a New Understanding of Assisted Living

The growth of assisted living communities is playing a pivotal role in how older adults live and access their medical care. That’s why PALTmed is holding Care Continuum 26: Embracing the Evolution of Assisted Living on January 28. The agenda for this inaugural virtual symposium includes a combination of pa...
Policy Snapshot

July 21, 2025

CMS Extends SNF Revalidation Deadline to January 2026

The Centers for Medicare & Medicaid Services (CMS) has extended the revalidation deadline for skilled nursing facilities (SNFs) from August 1, 2025, to January 1, 2026. This extension gives SNFs additional time to update and submit their Medicare enrollment information, as part of CMS’ broader effort t...
News Release

March 31, 2025

PALTmed Announces 2025-2026 Board of Directors

Post-Acute and Long-Term Care Medical Association (PALTmed) has elected its 2025-2026 Board of Directors. Sabine von Preyss-Friedman, MD, FACP, CMD, is president; Leslie Beth Eber, MD, CMD, is president-elect; and Diane Sanders-Cepeda, DO, CMD, is vice president.
Spotlight

January 6, 2026

2026 Filkin Lecture Features an Inside Look at State Survey Agencies

Amber Clark-Brown, MD, will be giving the much-anticipated Anne-Marie Filkin Lecture at this year’s PALTC26 annual conference in Anaheim, CA. As the only medical director working within a state survey agency (SSA), Dr. Clark-Brown will offer attendees her unique perspective and insights that she’s excited ...
JAMDA

December 15, 2014

A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD)

Neuropsychiatric symptoms in Alzheimer disease (AD) cause significant distress and present a complex clinical challenge for treatment. Pharmacological treatment options are limited to antipsychotics, which carry extensive safety issues. There is emerging evidence to support the potential benefits of memant...